Overexpression of CD80 on tumour cells expressing PD-L1 can attenuate the binding of PD-1 to tumours42, and abrogation of PD-1 function by cis-CD80:PD-L1 associations was proposed as a universal strategy to overcome PD-1 induced immune tolerance39. Here, CD80 is linked to neoplasm.